Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 3,578 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Sebaceous Hyperplasia
Interventions: Imiquimod 5% Topical Cream; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Testosterone Transdermal System, Placebo; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 20 Years to 70 Years · Female only
Enrollment: 562 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Metastatic Cancer
Interventions: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Breast Cancer, BIRADS 3, BIRADS 4, BIRADS 5
Interventions: DCE-MRI and DWI; Procedure
Lead sponsor: American College of Radiology Imaging Network; Network
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cancer
Interventions: Augmented Whole-body Scanning via Magnifying PET, PET/CT; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Peripheral Arterial Disease
Interventions: Not listed
Lead sponsor: TriReme Medical, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 13
States / cities: Phoenix, Arizona • Rancho Mirage, California • Gainesville, Florida + 9 more

Conditions: HIV Infections, Pregnancy
Interventions: Lopinavir/ritonavir, Ortho Novum 1/35, Ortho Evra; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2007
U.S. locations: 8
States / cities: Los Angeles, California • Aurora, Colorado • Honolulu, Hawaii + 3 more

Conditions: Peripheral Arterial Disease
Interventions: Tack Endovascular System; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 233 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 37
States / cities: Yuma, Arizona • Fremont, California • Denver, Colorado + 33 more

Conditions: Chronic Interstitial Cystitis
Interventions: LiRIS® 400 mg; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Daytona Beach, Florida • Royal Oak, Michigan

Conditions: Health Status Unknown, Elevated PSA
Interventions: Biopsy of Prostate, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, MRI Ultrasound Fusion Guided Biopsy; Procedure · Other · Diagnostic Test
Lead sponsor: University of Southern California; Other
Eligibility: 40 Years and older · Male only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 4
States / cities: Los Angeles, California • Baltimore, Maryland • Detroit, Michigan + 1 more

Conditions: Psoriasis
Interventions: Calcitriol ointment, Clobetasol spray; Drug
Lead sponsor: Emer, Jason, M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiac Surgery
Interventions: Pulse Oximeter; Device
Lead sponsor: Taiwan Aulisa Medical Devices Technologies, Inc.; Industry
Eligibility: 0 Days to 1 Year
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Lung Cancer, Lung Cancer Metastatic
Interventions: Porfimer Sodium, Fiber optic; Drug · Device
Lead sponsor: Concordia Laboratories Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 8
States / cities: Los Angeles, California • Denver, Colorado • Tampa, Florida + 5 more

Conditions: Atrial Fibrillation, Mitral Valve Insufficiency, Mitral Valve Stenosis
Interventions: MVS, Ablation; Procedure · Device
Lead sponsor: Annetine Gelijns; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 18
States / cities: New Haven, Connecticut • Newark, Delaware • Atlanta, Georgia + 14 more

Conditions: Menopause, Postmenopause, Premenopause, Cardiovascular Disease
Interventions: transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium); Drug
Lead sponsor: Northwestern University; Other
Eligibility: 47 Years to 55 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2005
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Depression, Psychosis, Anhedonia
Interventions: Transdermal Estradiol, Micronized Progesterone, Matching Placebo Patch, Raclopride C11; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking
Interventions: Nicorette, Tobacco Quit-line, Brief Behavioral Counseling, Intensive Behavioral Counseling; Drug · Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Rotator Cuff Tears, Shoulder Surgery
Interventions: Regeneten Collagen Patch; Device
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 40 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Coronary Artery Disease, Atherosclerosis
Interventions: NIRS/IVUS of coronary artery; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Lung; Node
Interventions: Robotic assisted bronchoscopy; Device
Lead sponsor: Auris Health, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 5
States / cities: Detroit, Michigan • St Louis, Missouri • Cleveland, Ohio + 2 more

Conditions: Watermelon Stomach
Interventions: cryotherapy, Argon Plasma Coagulation; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cigarette Smoking
Interventions: Nicotine Patch, Varenicline, Placebo Nicotine Patch, Placebo Capsule; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Knee Cartilage Defects
Interventions: CARTISTEM® + Debridement, Debridement; Biological · Procedure
Lead sponsor: Medipost, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 35
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tempe, Arizona + 29 more

Conditions: Pituitary Adenoma, Pituitary Tumor
Interventions: Surgical intervention for CNFA, Radiotherapy for CNFA; Procedure · Radiation
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2024
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Chocolate Balloon Angioplasty Registry

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries

A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis

Performance of Pulse Oximeter Sensors in Neonates

Safety of PDT-Photofrin® Prior to Lung Surgery

Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery

Midlife Cholesterol Study

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

Smoking Cessation Program in the Construction Sector

Regeneten Patch vs Standard Care in Partial Thickness Rotator Cuff Repair

Near-Infrared Spectroscopy and Ultrasound Investigation of Coronary Artery Plaque

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

Cyrotherapy vs. APC in GAVE

Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas